Arkolith/Insider Trading/CVKD/Form 4

Pham Quang X

CEO and Chairman, Director, 10% OwnerCadrenal Therapeutics, Inc. (CVKD) · full profile →Form 4 · filed Sep 5, 2023
Net Buying
Open-Market Buys
$64K
Open-Market Sells
$0
Net Open-Market Flow
$64K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 1, 2023Buy(P)10K$0.93$9K3.3M
Sep 1, 2023Buy(P)10K$0.84$8K3.4M
Sep 1, 2023Buy(P)10K$0.92$9K3.4M
Sep 1, 2023Buy(P)20K$0.93$19K3.3M
Sep 1, 2023Buy(P)20K$0.92$18K3.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-23-073551) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML